238 related articles for article (PubMed ID: 25268801)
21. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC
Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells modulate overt autoimmunity to homeostasis in nonobese diabetic mice after anti-CD3 F(ab')2 antibody treatment through secreting transforming growth factor-beta.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
Am J Pathol; 2009 Sep; 175(3):1086-94. PubMed ID: 19644014
[TBL] [Abstract][Full Text] [Related]
23. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
[TBL] [Abstract][Full Text] [Related]
24. Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.
Long SA; Thorpe J; Herold KC; Ehlers M; Sanda S; Lim N; Linsley PS; Nepom GT; Harris KM
Cell Immunol; 2017 Sep; 319():3-9. PubMed ID: 28844471
[TBL] [Abstract][Full Text] [Related]
25. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN
Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467
[TBL] [Abstract][Full Text] [Related]
26. Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells.
Takiishi T; Cook DP; Korf H; Sebastiani G; Mancarella F; Cunha JP; Wasserfall C; Casares N; Lasarte JJ; Steidler L; Rottiers P; Dotta F; Gysemans C; Mathieu C
Diabetes; 2017 Feb; 66(2):448-459. PubMed ID: 28108611
[TBL] [Abstract][Full Text] [Related]
27. The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice.
Sarikonda G; Sachithanantham S; Miller JF; Pagni PP; Coppieters KT; von Herrath M
J Autoimmun; 2015 May; 59():61-6. PubMed ID: 25772283
[TBL] [Abstract][Full Text] [Related]
28. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.
Kuhn C; Rezende RM; da Cunha AP; Valette F; Quintana FJ; Chatenoud L; Weiner HL
J Autoimmun; 2017 Jan; 76():115-122. PubMed ID: 27745778
[TBL] [Abstract][Full Text] [Related]
29. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
30. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.
Kim SJ; Nian C; Doudet DJ; McIntosh CH
Diabetes; 2009 Mar; 58(3):641-51. PubMed ID: 19073764
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD mice.
Zhang ZL; Constantinou D; Mandel TE; Georgiou HM
Autoimmunity; 1994; 17(1):41-8. PubMed ID: 8025213
[TBL] [Abstract][Full Text] [Related]
33. Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways.
Kim SJ; Nian C; McIntosh CH
Diabetes; 2010 Jul; 59(7):1739-50. PubMed ID: 20368408
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
Valle A; Barbagiovanni G; Jofra T; Stabilini A; Perol L; Baeyens A; Anand S; Cagnard N; Gagliani N; Piaggio E; Battaglia M
J Immunol; 2015 Mar; 194(5):2117-27. PubMed ID: 25646305
[TBL] [Abstract][Full Text] [Related]
35. Dreams for type 1 diabetes: shutting off autoimmunity and stimulating beta-cell regeneration.
Weir GC; Bonner-Weir S
Endocrinology; 2010 Jul; 151(7):2971-3. PubMed ID: 20570953
[No Abstract] [Full Text] [Related]
36. Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes.
Baeke F; Van Belle TL; Takiishi T; Ding L; Korf H; Laureys J; Gysemans C; Mathieu C
Diabetologia; 2012 Oct; 55(10):2723-2732. PubMed ID: 22752077
[TBL] [Abstract][Full Text] [Related]
37. Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models.
Lasch S; Müller P; Bayer M; Pfeilschifter JM; Luster AD; Hintermann E; Christen U
Diabetes; 2015 Dec; 64(12):4198-211. PubMed ID: 26293506
[TBL] [Abstract][Full Text] [Related]
38. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.
Parker MJ; Xue S; Alexander JJ; Wasserfall CH; Campbell-Thompson ML; Battaglia M; Gregori S; Mathews CE; Song S; Troutt M; Eisenbeis S; Williams J; Schatz DA; Haller MJ; Atkinson MA
Diabetes; 2009 Oct; 58(10):2277-84. PubMed ID: 19628781
[TBL] [Abstract][Full Text] [Related]
39. Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.
Waldron-Lynch F; von Herrath M; Herold KC
Novartis Found Symp; 2008; 292():146-55; discussion 155-8, 202-3. PubMed ID: 19203097
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
